U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C19H19FN4O2
Molecular Weight 354.3782
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AZD-7325

SMILES

CCCNC(=O)C1=C(N)C2=C(N=N1)C(=CC=C2)C3=C(F)C=CC=C3OC

InChI

InChIKey=KYDURMHFWXCKMW-UHFFFAOYSA-N
InChI=1S/C19H19FN4O2/c1-3-10-22-19(25)18-16(21)12-7-4-6-11(17(12)23-24-18)15-13(20)8-5-9-14(15)26-2/h4-9H,3,10H2,1-2H3,(H2,21,23)(H,22,25)

HIDE SMILES / InChI

Molecular Formula C19H19FN4O2
Molecular Weight 354.3782
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Development and SAR of functionally selective allosteric modulators of GABAA receptors.
2011 May 1
Patents
Substance Class Chemical
Created
by admin
on Sat Dec 16 01:52:29 GMT 2023
Edited
by admin
on Sat Dec 16 01:52:29 GMT 2023
Record UNII
KNM216XOUH
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AZD-7325
Common Name English
3-CINNOLINECARBOXAMIDE, 4-AMINO-8-(2-FLUORO-6-METHOXYPHENYL)-N-PROPYL-
Systematic Name English
AZD 7325 [WHO-DD]
Common Name English
Code System Code Type Description
PUBCHEM
23581869
Created by admin on Sat Dec 16 01:52:29 GMT 2023 , Edited by admin on Sat Dec 16 01:52:29 GMT 2023
PRIMARY
CAS
942437-37-8
Created by admin on Sat Dec 16 01:52:29 GMT 2023 , Edited by admin on Sat Dec 16 01:52:29 GMT 2023
PRIMARY
DRUG BANK
DB13994
Created by admin on Sat Dec 16 01:52:29 GMT 2023 , Edited by admin on Sat Dec 16 01:52:29 GMT 2023
PRIMARY
ChEMBL
CHEMBL1783282
Created by admin on Sat Dec 16 01:52:29 GMT 2023 , Edited by admin on Sat Dec 16 01:52:29 GMT 2023
PRIMARY
FDA UNII
KNM216XOUH
Created by admin on Sat Dec 16 01:52:29 GMT 2023 , Edited by admin on Sat Dec 16 01:52:29 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
METABOLITE -> PARENT
PLASMA
METABOLITE -> PARENT
PLASMA
METABOLITE -> PARENT
PLASMA
METABOLITE -> PARENT
PLASMA
METABOLITE -> PARENT
PLASMA
METABOLITE -> PARENT
PLASMA
METABOLITE -> PARENT
Metabolites M9, M10, and M42 were either minor or absent in plasma samples after a single dose; however, all became major metabolites in human and preclinical animal plasma after repeated doses and circulated in humans longer than 48 hours after the end of seven repeated doses
PLASMA
METABOLITE -> PARENT
PLASMA
METABOLITE -> PARENT
Metabolites M9, M10, and M42 were either minor or absent in plasma samples after a single dose; however, all became major metabolites in human and preclinical animal plasma after repeated doses and circulated in humans longer than 48 hours after the end of seven repeated doses
PLASMA
Related Record Type Details
ACTIVE MOIETY